PMID- 19171986 OWN - NLM STAT- MEDLINE DCOM- 20091116 LR - 20220321 IS - 0973-3922 (Electronic) IS - 0378-6323 (Linking) VI - 74 IP - 6 DP - 2008 Nov-Dec TI - Immune reconstitution inflammatory syndrome. PG - 619-21 AB - BACKGROUND: Immune reconstitution inflammatory syndrome (IRIS) is a paradoxical deterioration in clinical status in a patient on antiretroviral treatment (ART) despite satisfactory control of viral replication and improvement of CD4 count. AIM: To study development of IRIS as a part of ART. METHODS: Hundred patients on antiretroviral treatment were studied prospectively in the Department of Skin and VD over a period of 2 years. Patients were asked to come if they developed any symptoms or on a monthly basis. They were screened clinically and investigated suitably for evidence of opportunistic infections. RESULTS: Out of 100 patients, 10 patients did not come for follow-up. Twenty (22.2%) out of the 90 patients developed IRIS. Herpes zoster (HZ), herpes simplex virus (HSV), and tuberculosis (TB) were the cases of IRIS seen in the present study. CONCLUSIONS: IRIS in terms of HSV/TB is known to accelerate HIV disease progression. Hence early detection and prompt treatment, along with continuation of highly active ART, are of utmost importance. FAU - Sharma, Ajay AU - Sharma A AD - Department of Skin and V.D., Medical College and SSG Hospital, Vadodara, India. FAU - Makrandi, Smita AU - Makrandi S FAU - Modi, Megha AU - Modi M FAU - Sharma, Archana AU - Sharma A FAU - Marfatia, Yogesh AU - Marfatia Y LA - eng PT - Comparative Study PT - Journal Article PL - United States TA - Indian J Dermatol Venereol Leprol JT - Indian journal of dermatology, venereology and leprology JID - 7701852 RN - 0 (Anti-Retroviral Agents) SB - IM MH - Anti-Retroviral Agents/adverse effects/therapeutic use MH - CD4 Lymphocyte Count/methods MH - Follow-Up Studies MH - HIV Infections/complications/drug therapy/pathology MH - Humans MH - Immune Reconstitution Inflammatory Syndrome/chemically induced/complications/*diagnosis/*pathology MH - Prospective Studies EDAT- 2009/01/28 09:00 MHDA- 2009/11/17 06:00 CRDT- 2009/01/28 09:00 PHST- 2009/01/28 09:00 [entrez] PHST- 2009/01/28 09:00 [pubmed] PHST- 2009/11/17 06:00 [medline] AID - 10.4103/0378-6323.45105 [doi] PST - ppublish SO - Indian J Dermatol Venereol Leprol. 2008 Nov-Dec;74(6):619-21. doi: 10.4103/0378-6323.45105.